SHINGRIX
Recombinant varicella-zoster glycoprotein E, adjuvanted · Shingles (Shingrix)
Health Canada DIN 02468425. Check the product and formulation on your record before using a schedule.
Plan doses for this product →At a glance
- Brand
- SHINGRIX
- DIN
02468425- Vaccine
- Recombinant varicella-zoster glycoprotein E, adjuvanted
- Presentation
- 50 mcg / 0.5 mL · suspension · intramuscular · 50 and older, or 18 and older if immunocompromised
- Live vaccine
- No
Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with the Care365 clinical team or doctor.
Official product information
Use the DIN to confirm this exact product in Health Canada's Drug Product Database.
Read product monograph (PDF) ↗
A listed product may not be stocked or publicly funded.
Dose schedules involving this product
These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination.
| Schedule | Doses | Who it applies to |
|---|---|---|
| Shingles (Shingrix) — adults 50 and older, two doses Two doses of recombinant zoster vaccine, 2 to 6 months apart. | 2 doses | For adults 50 years of age and older, including those who have had shingles or an earlier live shingles vaccine. Dose 2 is given 2 to 6 months after dose 1 (a 12-month interval is also acceptable). |
| Shingles (Shingrix) — weakened immune system, 18 and older, two doses Two doses; the second can be given as soon as 4 weeks after the first when faster protection matters. | 2 doses | For adults 18 years and older who are, or will be, immunocompromised. The usual interval is 2 to 6 months; the second dose may be given at a minimum of 4 weeks after the first when completing the series sooner is beneficial, ideally at least 14 days before immunosuppressive therapy starts. |
Pregnancy and breastfeeding
Family guidance on pregnancy: Currently not recommended; deferred until after pregnancy.
Family guidance on breastfeeding: Use if indicated.
This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.
Sources and next steps
- Herpes zoster (shingles) vaccine: Canadian Immunization Guide — Chapter revised August 2018 · partial update June 2025
- Health Canada product record
General information only. A suggested date is not an appointment or a prescription; the Care365 clinical team or doctor confirms what you need. Clinical rules reviewed on 2026-09-27.
Review with Care365